Clinical Trial Update: Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports safety and preliminary efficacy results for AKB-9778 in diabetic macular edema from Phase 1/2 studies, which have completed e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• AKB-9778

Snippet

Sponsor: Aerpio Therapeutics | Conditions: Diabetic Macular Edema (DME) | Phase 1, Phase 2 | Status: COMPLETED